Market Recap - Monday March 9, 2026
Markets rebound as hopes for an Iran conflict off-ramp send oil sharply lower
US stocks rallied Monday as investors reacted to signs that the conflict involving Iran may be nearing an end. The Dow Jones rose 0.50%, the S&P 500 gained 0.83%, the Nasdaq jumped 1.38%, and the Russell 2000 climbed 1.12%, with markets finishing close to their highs of the day.
The turnaround came after a volatile start to the session. Earlier in the day, oil prices briefly surged above $100 per barrel — their highest level since 2022 — as concerns grew about disruptions to energy supplies from the Middle East. But sentiment shifted dramatically later in the afternoon after President Trump suggested the war with Iran could be nearing completion and hinted at plans to secure the Strait of Hormuz, a key route for global oil shipments. Those comments sparked a rally in stocks and a sharp drop in oil prices from their earlier highs.
Technology stocks helped lead the market higher. Major companies such as Nvidia and Alphabet were among the standout performers, while high-growth and momentum stocks — many of which had been heavily sold in recent sessions — also rebounded. Semiconductor companies, industrial metals, travel and transportation stocks all posted strong gains as investors moved back into riskier parts of the market.
Energy stocks were among the few sectors that struggled as oil prices pulled back from their earlier surge. Defensive areas such as insurance and telecom also lagged as investors rotated back toward growth-oriented stocks.
Bond yields fell modestly, particularly for longer-term Treasury bonds, suggesting investors were dialing back some of their inflation concerns after the drop in oil prices. The US dollar weakened slightly, while gold declined as safe-haven demand eased.
There was little economic data released Monday, though the New York Fed’s survey of consumer expectationsshowed that Americans’ one-year inflation expectations edged down slightly to 3.0%. Markets are now turning their attention to a busy week ahead for economic reports, including February inflation data (CPI) on Wednesday, which will provide the next major signal about the path of inflation and interest rates.
Corporate news also helped drive some individual stock moves. Hims & Hers Health surged more than 40% on reports that the company could partner with Novo Nordisk to distribute popular weight-loss drugs. Xenon Pharmaceuticals jumped nearly 50% after announcing positive results from a late-stage epilepsy drug trial. Meanwhile, several companies — including Vertiv, Lumentum, and Coherent — moved higher after being added to the S&P 500 index, a change that will take effect later this month.
Here’s Our Take
Today’s rally shows just how sensitive markets remain to developments in the Middle East, particularly when those developments affect energy prices. Oil has become the key channel through which geopolitical news is influencing financial markets.
When oil surged earlier in the day, stocks initially fell as investors worried about inflation and economic growth. But once comments from the White House suggested the conflict could wind down sooner than expected, markets quickly reversed course.
This pattern highlights an important theme for investors: markets are currently being driven more by headlines and expectations than by fundamental changes in the economy.
At the same time, the broader economic backdrop still appears relatively stable. Inflation expectations remain contained, corporate earnings are expected to grow strongly this year, and the labor market — despite last week’s weak payroll report — has not yet shown signs of a severe downturn.
The next major catalyst for markets will likely be Wednesday’s inflation report, which could shape expectations for Federal Reserve policy and help determine whether last week’s rise in bond yields continues or begins to reverse.
For now, volatility may remain elevated, but today’s rebound suggests investors are still willing to buy dips when geopolitical fears begin to fade.
P.S. Know someone who’d appreciate smarter stock insights and clearer investing strategies? Forward this email or share this link: subscribe.triplegains.com
Triple Gains - Stock Analysis - Thematic Insights - Portfolio Strategy
DISCLAIMER: The content provided in this newsletter does not constitute investment advice, financial advice, trading advice, or any other form of personal recommendation. Nothing in this newsletter should be interpreted as a suggestion to buy, sell, or hold any investment or security. All content is for general informational purposes only and should not be relied upon for making investment decisions. Readers should conduct their own research and consult qualified financial advisors before making any investment decisions. To read our full disclaimer, click here.